Carisma Therapeutics Inc. (CARM) — Cash Flow Quality Index
Carisma Therapeutics Inc. (CARM) has a Cash Flow Quality Index of 0.04x as of September 2025. Operating cash flow of $1.91 Million is below net income of $44.72 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Carisma Therapeutics Inc. (CARM) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Carisma Therapeutics Inc. Cash Flow Quality Index (2016–2016)
Historical Cash Flow Quality Index for Carisma Therapeutics Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Carisma Therapeutics Inc..
Annual Cash Flow Quality Index for Carisma Therapeutics Inc. (2016–2016)
Year-by-year earnings quality comparison for Carisma Therapeutics Inc..
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | 1.39x | $2.62 Million | $1.89 Million | — |